Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 4 months ago

Possible Interaction: Glycopeptides and Vancomycin

supplement:

Glycopeptides

Research Papers that Mention the Interaction

The newer glycopeptides and linezolid decrease the total treatment costs compared with vancomycin , by reducing the length of stay or avoiding the hospitalization.
The newer glycopeptides and linezolid decrease the total treatment costs compared with vancomycin , by reducing the length of stay or avoiding the hospitalization.
Current opinion in infectious diseases  •  2017  |  View Paper
This case report describes a methicillin-resistant Staphylococcus aureus isolated repeatedly from the blood of a patient with community-acquired endocarditis who developed a four-fold increase in the minimal inhibitory concentration of vancomycin and daptomycin 7 months after his last exposure to glycopeptide antibiotics.
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi  •  2016  |  View Paper
FINDINGS The lipoglycopeptides are approximately 4- to 8-fold more potent than vancomycin against gram-positive organisms, including activity against vancomycin-intermediate or vancomycin-resistant strains of Staphylococcus and Enterococcus species.
Clinical therapeutics  •  2015  |  View Paper
Resistance to glycopeptide antibiotics, especially vancomycin is of special concern.
The Indian journal of medical research  •  2013  |  View Paper
Of 63 patients treated with vancomycin, only 14 (22.6%) patients had aimed trough levels of 15-20 mg/L. Vancomycin MIC ≥2 mg/L was detected in 28.2% and was associated with glycopeptide pretreatment (p 0.001).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases  •  2013  |  View Paper
The clinical success of vancomycin in the treatment of multiresistant Gram-positive bacteria has stimulated further development of glycopeptide antibiotics and research of other Lipid II-binding compounds.
Current opinion in investigational drugs  •  2010  |  View Paper
ST1-MRSA-I (1 out of 2 strains carrying ccr A2B2), ST8-MRSA-I (4 strains), ST15-… earliest STs among the MRSA strains in 1980.A temporal shift in the susceptibility levels to glycopeptides … vancomycin MIC of ≥ 2 mg/L increased from … glycopeptide MIC levels, reflecting a worldwide trend.
Annals of Clinical Microbiology and Antimicrobials  •  2009  |  View Paper
improper use of vancomycin and due to cross resistance from other glycopeptides like teicoplanin.
Indian journal of medical microbiology  •  2007  |  View Paper
Chronic osteomyelitis was the most common type of infection, and prolonged exposure to glycopeptides was associated with reduced susceptibility to vancomycin.
Microbial drug resistance  •  2006  |  View Paper
However induction with vancomycin increased glycopeptide MICs and stabilized the resistance.
Antimicrobial agents and chemotherapy  •  2004  |  View Paper
Show More